A phase I pilot study of ISA101 in combination with chemotherapy in patients with advanced cervical carcinoma

Trial Profile

A phase I pilot study of ISA101 in combination with chemotherapy in patients with advanced cervical carcinoma

Completed
Phase of Trial: Phase I

Latest Information Update: 29 May 2014

At a glance

  • Drugs ISA 101 (Primary) ; Carboplatin; Paclitaxel
  • Indications Cervical cancer; Human papillomavirus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 29 May 2014 New trial record
    • 07 Apr 2014 Summary of ISA101 programme as reported in the 105th Annual Meeting of the American Association for Cancer Research.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top